Anv Sec Group Inc.https://investorshangout.com/Anv-Sec-Group-Inc-ANVS-58416/en-usWed, 09 Sep 2026 02:39:15 GMTCopyright InvestorsHangout.comNetworkNewsWire: The Brain’s ‘Cleanup Crew’ Could Hold the Key to Alzheimer’s Treatment, Study Shows A new https://investorshangout.com/post/view?id=6750346https://investorshangout.com/post/view?id=6750346Fri, 14 Mar 2025 20:42:59 GMTNetworkNewsWire: NetworkNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) to Present at Alzheimer’s & Parkinson’s Drug Dehttps://investorshangout.com/post/view?id=6749745https://investorshangout.com/post/view?id=6749745Tue, 11 Mar 2025 20:02:57 GMTNetworkNewsWire: NetworkNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) to Host Patient Forum on Alzheimer’s and Parkinhttps://investorshangout.com/post/view?id=6745835https://investorshangout.com/post/view?id=6745835Wed, 19 Feb 2025 21:37:11 GMTNetworkNewsWire: Ongoing Trial Seeks to Avert Alzheimer’s Decades Before it Strikes An ongoing clinical trihttps://investorshangout.com/post/view?id=6744816https://investorshangout.com/post/view?id=6744816Thu, 13 Feb 2025 21:36:12 GMTNetworkNewsWire: NetworkNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) CEO to Present at Oppenheimer Healthcare Conferhttps://investorshangout.com/post/view?id=6743718https://investorshangout.com/post/view?id=6743718Fri, 07 Feb 2025 21:29:30 GMTNetworkNewsWire: NetworkNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Enrolls First Patients in Phase 3 Alzheimer’s Thttps://investorshangout.com/post/view?id=6743459https://investorshangout.com/post/view?id=6743459Thu, 06 Feb 2025 20:26:24 GMTNetworkNewsWire: NetworkNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Closes $21M Public Offering to Advance Alzheimehttps://investorshangout.com/post/view?id=6743192https://investorshangout.com/post/view?id=6743192Wed, 05 Feb 2025 20:43:35 GMTNetworkNewsWire: NetworkNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Closes $21M Public Offering to Advance Alzheimehttps://investorshangout.com/post/view?id=6743191https://investorshangout.com/post/view?id=6743191Wed, 05 Feb 2025 20:43:05 GMTNetworkNewsWire: NetworkNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Prices $21 Million Public Offering Annovhttps://investorshangout.com/post/view?id=6742700https://investorshangout.com/post/view?id=6742700Mon, 03 Feb 2025 21:22:25 GMTNetworkNewsWire: US Announces Plan to Combat Parkinson’s Disease Across the Country Last week, the Nationalhttps://investorshangout.com/post/view?id=6741286https://investorshangout.com/post/view?id=6741286Fri, 24 Jan 2025 21:39:15 GMTNetworkNewsWire: NetworkNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Secures U.S. Patent for Acute Neurodegenerativehttps://investorshangout.com/post/view?id=6739637https://investorshangout.com/post/view?id=6739637Tue, 14 Jan 2025 21:13:11 GMTNetworkNewsWire: NetworkNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Announces Streamlined Pathway to Advance Buntanhttps://investorshangout.com/post/view?id=6738748https://investorshangout.com/post/view?id=6738748Tue, 07 Jan 2025 21:48:01 GMTNetworkNewsWire: Study Uncovers Link Between Gut Infection and Alzheimer’s Disease Cytomegalovirus is a typhttps://investorshangout.com/post/view?id=6738034https://investorshangout.com/post/view?id=6738034Thu, 02 Jan 2025 21:51:27 GMTNetworkNewsWire: NetworkNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Eyes Opportunities Beyond ‘Year of Significant https://investorshangout.com/post/view?id=6737277https://investorshangout.com/post/view?id=6737277Fri, 27 Dec 2024 19:52:49 GMTNetworkNewsWire: NetworkNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Committed to Ensuring Highest Standards in Conthttps://investorshangout.com/post/view?id=6736510https://investorshangout.com/post/view?id=6736510Fri, 20 Dec 2024 21:06:23 GMTNetworkNewsWire: NetworkNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Eyes Clear Path Forward for Buntanetap Ahttps://investorshangout.com/post/view?id=6735668https://investorshangout.com/post/view?id=6735668Mon, 16 Dec 2024 20:55:26 GMTNetworkNewsWire: Annovis Bio Inc. (NYSE: ANVS) Showcases 2024 Achievements and Strategic Vision in Year-End Investhttps://investorshangout.com/post/view?id=6735331https://investorshangout.com/post/view?id=6735331Fri, 13 Dec 2024 21:02:51 GMTNetworkNewsWire: New Staging System Could Forecast How Quickly Parkinson’s Might Progress After Diagnosis Ihttps://investorshangout.com/post/view?id=6734737https://investorshangout.com/post/view?id=6734737Tue, 10 Dec 2024 21:45:25 GMTNetworkNewsWire: NetworkNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) CEO Highlights Innovations in Neurodegenerativehttps://investorshangout.com/post/view?id=6733682https://investorshangout.com/post/view?id=6733682Thu, 05 Dec 2024 20:17:07 GMTNetworkNewsWire: NetworkNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) CEO Shares Insight on Breakthrough Drug Showinghttps://investorshangout.com/post/view?id=6733476https://investorshangout.com/post/view?id=6733476Wed, 04 Dec 2024 21:12:47 GMTNetworkNewsWire: Annovis Bio Inc. (NYSE: ANVS) to Present Recent Achievements and 2025 Strategic Outlook During Uphttps://investorshangout.com/post/view?id=6733212https://investorshangout.com/post/view?id=6733212Tue, 03 Dec 2024 20:13:25 GMTNetworkNewsWire: NetworkNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Schedules Investor Webcast to Share Clinical anhttps://investorshangout.com/post/view?id=6731862https://investorshangout.com/post/view?id=6731862Mon, 25 Nov 2024 20:25:16 GMTNetworkNewsWire: Research Suggests Cancer Survivors are Less Prone to Alzheimer’s Development Alzheimer’s ahttps://investorshangout.com/post/view?id=6731076https://investorshangout.com/post/view?id=6731076Thu, 21 Nov 2024 21:44:39 GMTNetworkNewsWire: NetworkNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Paving the Way for NDA Submission Annovihttps://investorshangout.com/post/view?id=6730593https://investorshangout.com/post/view?id=6730593Tue, 19 Nov 2024 20:19:37 GMTNetworkNewsWire: NetworkNewsBreaks – Annovis Bio Inc. CEO to Showcase Buntanetap’s Dual Benefits for Alzheimer’s ahttps://investorshangout.com/post/view?id=6729065https://investorshangout.com/post/view?id=6729065Tue, 12 Nov 2024 20:29:22 GMTNetworkNewsWire: NetworkNewsBreaks – Annovis Bio Inc. Advances Alzheimer’s Phase 3 Trials with Strong FDA Support https://investorshangout.com/post/view?id=6728822https://investorshangout.com/post/view?id=6728822Mon, 11 Nov 2024 20:32:57 GMTNetworkNewsWire: NetworkNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Strengthens Clinical Research Team with Appointhttps://investorshangout.com/post/view?id=6728126https://investorshangout.com/post/view?id=6728126Thu, 07 Nov 2024 20:15:58 GMTNetworkNewsWire: Annovis Bio Inc. (NYSE: ANVS) Highlights Buntanetap Results at 17th Clinical Trials on Alzheimer’https://investorshangout.com/post/view?id=6727634https://investorshangout.com/post/view?id=6727634Tue, 05 Nov 2024 19:58:26 GMTNetworkNewsWire: Study Explores How Antimicrobials Impact the Risk of Developing Parkinson’s Disease A new https://investorshangout.com/post/view?id=6727002https://investorshangout.com/post/view?id=6727002Fri, 01 Nov 2024 21:26:36 GMTNetworkNewsWire: NetworkNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) CEO Details Promising Phase 3 Path for Alzheimehttps://investorshangout.com/post/view?id=6726827https://investorshangout.com/post/view?id=6726827Thu, 31 Oct 2024 21:34:46 GMTNetworkNewsWire: NetworkNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Moving Closer to Providing Much-Needed Treatmenhttps://investorshangout.com/post/view?id=6726314https://investorshangout.com/post/view?id=6726314Tue, 29 Oct 2024 20:16:25 GMTNetworkNewsWire: Annovis Bio Inc. (NYSE: ANVS) Gets FDA Clearance for Buntanetap Pivotal Phase 3 Trials, Market Enhttps://investorshangout.com/post/view?id=6725686https://investorshangout.com/post/view?id=6725686Fri, 25 Oct 2024 20:48:00 GMTNetworkNewsWire: Annovis Bio Inc. (NYSE: ANVS) Receives FDA Clearance to Initiate Pivotal Phase 3 Alzheimer’s Studhttps://investorshangout.com/post/view?id=6725248https://investorshangout.com/post/view?id=6725248Wed, 23 Oct 2024 20:31:24 GMTNetworkNewsWire: NetworkNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) to Present Key Alzheimer’s Research at CTAD Conhttps://investorshangout.com/post/view?id=6725078https://investorshangout.com/post/view?id=6725078Tue, 22 Oct 2024 20:47:03 GMTNetworkNewsWire: Analysis of Medical Records Repeatedly Links Viruses to Alzheimer’s New research has obserhttps://investorshangout.com/post/view?id=6724164https://investorshangout.com/post/view?id=6724164Thu, 17 Oct 2024 07:47:20 GMTNetworkNewsWire: NetworkNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Receives FDA Clearance for Pivotal Phase 3 Alzhhttps://investorshangout.com/post/view?id=6723873https://investorshangout.com/post/view?id=6723873Tue, 15 Oct 2024 20:31:06 GMTNetworkNewsWire: Annovis Bio Inc. (NYSE: ANVS) Seeking to Strengthen Intellectual Property Portfolio, Protecting Mhttps://investorshangout.com/post/view?id=6721948https://investorshangout.com/post/view?id=6721948Fri, 04 Oct 2024 20:59:23 GMTNetworkNewsWire: Transforming Alzheimer’s Treatment: Innovative Combinations to Boost Cognition NetworkNewshttps://investorshangout.com/post/view?id=6721342https://investorshangout.com/post/view?id=6721342Tue, 01 Oct 2024 21:30:12 GMTNetworkNewsWire: NetworkNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Announces Filing of Three Patents Covering Combhttps://investorshangout.com/post/view?id=6721116https://investorshangout.com/post/view?id=6721116Mon, 30 Sep 2024 20:49:39 GMTNetworkNewsWire: Addressing Vision Problems Could Lower Risk of Dementia, Study Finds New research suggestshttps://investorshangout.com/post/view?id=6720824https://investorshangout.com/post/view?id=6720824Fri, 27 Sep 2024 21:41:18 GMTNetworkNewsWire: Annovis Bio Inc. (NYSE: ANVS) Presented Recent Achievements and Strategic Direction at H.C. Wainwhttps://investorshangout.com/post/view?id=6720365https://investorshangout.com/post/view?id=6720365Wed, 25 Sep 2024 21:26:39 GMTNetworkNewsWire: NetworkNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Stands Distinct from Industry Players with Bunthttps://investorshangout.com/post/view?id=6719507https://investorshangout.com/post/view?id=6719507Fri, 20 Sep 2024 21:09:55 GMTNetworkNewsWire: Expert Says Alzheimer’s Disease Could Be an Autoimmune Illness Alzheimer’s is a progressivhttps://investorshangout.com/post/view?id=6717047https://investorshangout.com/post/view?id=6717047Fri, 06 Sep 2024 21:18:14 GMTNetworkNewsWire: NetworkNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) to Participate at the H.C. Wainwright 26th Annuhttps://investorshangout.com/post/view?id=6716859https://investorshangout.com/post/view?id=6716859Thu, 05 Sep 2024 20:59:06 GMTNetworkNewsWire: Annovis Bio Inc. (NYSE: ANVS) Announces Encouraging Clinical Trial Results, IP Portfolio Enhancemhttps://investorshangout.com/post/view?id=6715538https://investorshangout.com/post/view?id=6715538Mon, 26 Aug 2024 21:07:42 GMTNetworkNewsWire: Annovis Bio Inc. (NYSE: ANVS) CEO Discusses Findings of Buntanetap Phase 2/3 Alzheimer’s Study onhttps://investorshangout.com/post/view?id=6714430https://investorshangout.com/post/view?id=6714430Tue, 20 Aug 2024 20:25:13 GMTNetworkNewsWire: NetworkNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Announces Q2 2024 Financial Results, Provides Uhttps://investorshangout.com/post/view?id=6713179https://investorshangout.com/post/view?id=6713179Thu, 15 Aug 2024 20:13:19 GMTNetworkNewsWire: Studies Show Protein, Reelin, Protects Brain Against Alzheimer’s, Aging Researchers conduchttps://investorshangout.com/post/view?id=6712562https://investorshangout.com/post/view?id=6712562Wed, 14 Aug 2024 20:58:49 GMTNetworkNewsWire: Annovis Bio Inc. (NYSE: ANVS) Lead Compound Shows Synergistic Cognitive Enhancement - Annohttps://investorshangout.com/post/view?id=6712536https://investorshangout.com/post/view?id=6712536Wed, 14 Aug 2024 19:52:14 GMTNetworkNewsWire: NetworkNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Given $21.00 Price Target by EF Hutton Ahttps://investorshangout.com/post/view?id=6712529https://investorshangout.com/post/view?id=6712529Wed, 14 Aug 2024 19:39:44 GMT